A.I. Ivanov1,3,4, M.V. Burmistrov2,3, V.A. Popov2-4, A.A. Emelyanova1, S.I. Bebezov1
1Tatarstan Саnсеr Center, Kazan
2Republican Clinical Hospital of the MH of RT, Kazan
3Kazan State Medical Academy — Branch Campus of Russian Medical Academy of Continuing Professional Education of the MH of RF, Kazan
4Volga Region branch of N.N. Blokhin National Medical Research Center of Oncology of the MH of RF, Kazan
Popov V.A. ― postgraduate student of the Department of Endoscopy, General and Endoscopic Surgery of Kazan State Medical Academy — Branch Campus of Russian Medical Academy of Continuing Professional Education of the MH of RF, Scientific Secretary of the Volga Region branch of N.N. Blokhin National Medical Research Center of Oncology of the MH of RF, Junior Researcher of the Research Department of Republican Clinical Hospital of the MH of RT, endoscopist of the Republican Clinical Hospital of the MH of RT
138 Orenburgskiy trakt, Kazan, Russian Federation, 420064, tel. +7-999-156-88-20, e-mail: email@example.com
Abstract. Most esophageal carcinomas are diagnosed at a late stage, leaving palliative care as a more realistic choice for this group of patients. Dysphagia in this case is the leading symptom, which leads to cachexy, a decrease in the quality and duration of life. Stenting is a relatively safe method of choice for malignant esophageal obstruction, allowing you to quickly and effectively eliminate the symptoms of dysphagia. However, to date, there is no consensus in choosing the optimal method of palliative care for this group of patients. In order to study this problem, this work has been done. The article analyzes the life expectancy of 193 patients with implanted esophageal stents with various malignant pathology of the esophagus and esophageal-gastric junction. The data of survival of patients depending on the localization of malignant process and histological type of tumors are presented.
Key words: esophageal stenting, esophageal carcinoma, life expectancy, survival.